Showing posts with label Clostridium Difficile Associated Diarrhea and Staphylococcus Aureus Colitis. Show all posts
Showing posts with label Clostridium Difficile Associated Diarrhea and Staphylococcus Aureus Colitis. Show all posts
Friday, April 20, 2018

CutisPharma Announces FDA Approval of Firvanq (vancomycin) for Treatment of Clostridium Difficile Associated Diarrhea and Staphylococcus Aureus Colitis

›
In continuation of my update on  vancomycin CutisPharma announced  the US Food and Drug Administration (FDA)  approval of  Firva...